2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

C82H121B3Cl2N18O6 — CID 161342767

IUPAC2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
SMILESCc1[nH]ncc1B1OC(C)(C)C(C)(C)O1.Cc1c(-c2cnc3ccc(Cl)nc3c2)cnn1CCCN1CCCC1.Cc1c(B2OC(C)(C)C(C)(C)O2)cnn1CCCN1CCCC1.Cc1nn(CCCN2CCCC2)cc1-c1cnc2ccc(Cl)nc2c1.Cc1nn(CCCN2CCCC2)cc1B1OC(C)(C)C(C)(C)O1
InChIInChI=1S/2C19H22ClN5.2C17H30BN3O2.C10H17BN2O2/c1-14-16(13-25(23-14)10-4-9-24-7-2-3-8-24)15-11-18-17(21-12-15)5-6-19(20)22-18;1-14-16(13-22-25(14)10-4-9-24-7-2-3-8-24)15-11-18-17(21-12-15)5-6-19(20)23-18;1-14-15(18-22-16(2,3)17(4,5)23-18)13-21(19-14)12-8-11-20-9-6-7-10-20;1-14-15(18-22-16(2,3)17(4,5)23-18)13-19-21(14)12-8-11-20-9-6-7-10-20;1-7-8(6-12-13-7)11-14-9(2,3)10(4,5)15-11/h2*5-6,11-13H,2-4,7-10H2,1H3;2*13H,6-12H2,1-5H3;6H,1-5H3,(H,12,13)
InChIKeyVMWWCFAIXFQCOT-UHFFFAOYSA-N
MW1558.33 g/mol
LogP12.85
Rot. Bonds21

About 2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (PubChem CID 161342767) has the molecular formula C82H121B3Cl2N18O6 and a molecular weight of 1558.33 g/mol. Its IUPAC name is 2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole.

Molecular Properties

Compound Name2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
PubChem CID161342767
Molecular FormulaC82H121B3Cl2N18O6
Molecular Weight1558.33 g/mol
Exact Mass1556.94
IUPAC Name2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
SMILESCc1[nH]ncc1B1OC(C)(C)C(C)(C)O1.Cc1c(-c2cnc3ccc(Cl)nc3c2)cnn1CCCN1CCCC1.Cc1c(B2OC(C)(C)C(C)(C)O2)cnn1CCCN1CCCC1.Cc1nn(CCCN2CCCC2)cc1-c1cnc2ccc(Cl)nc2c1.Cc1nn(CCCN2CCCC2)cc1B1OC(C)(C)C(C)(C)O1
InChIInChI=1S/2C19H22ClN5.2C17H30BN3O2.C10H17BN2O2/c1-14-16(13-25(23-14)10-4-9-24-7-2-3-8-24)15-11-18-17(21-12-15)5-6-19(20)22-18;1-14-16(13-22-25(14)10-4-9-24-7-2-3-8-24)15-11-18-17(21-12-15)5-6-19(20)23-18;1-14-15(18-22-16(2,3)17(4,5)23-18)13-21(19-14)12-8-11-20-9-6-7-10-20;1-14-15(18-22-16(2,3)17(4,5)23-18)13-19-21(14)12-8-11-20-9-6-7-10-20;1-7-8(6-12-13-7)11-14-9(2,3)10(4,5)15-11/h2*5-6,11-13H,2-4,7-10H2,1H3;2*13H,6-12H2,1-5H3;6H,1-5H3,(H,12,13)
InChIKeyVMWWCFAIXFQCOT-UHFFFAOYSA-N
XLogP12.85
TPSA219.86 Ų
H-Bond Donors1
H-Bond Acceptors23
Rotatable Bonds21
Heavy Atoms111
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001558.33
LogP ≤ 512.85
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole?
The IUPAC name of 2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (CID 161342767) is 2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole.
What is the SMILES notation for 2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole?
The canonical SMILES for 2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is Cc1[nH]ncc1B1OC(C)(C)C(C)(C)O1.Cc1c(-c2cnc3ccc(Cl)nc3c2)cnn1CCCN1CCCC1.Cc1c(B2OC(C)(C)C(C)(C)O2)cnn1CCCN1CCCC1.Cc1nn(CCCN2CCCC2)cc1-c1cnc2ccc(Cl)nc2c1.Cc1nn(CCCN2CCCC2)cc1B1OC(C)(C)C(C)(C)O1.
What is the InChIKey of 2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole?
The InChIKey is VMWWCFAIXFQCOT-UHFFFAOYSA-N. The full InChI is InChI=1S/2C19H22ClN5.2C17H30BN3O2.C10H17BN2O2/c1-14-16(13-25(23-14)10-4-9-24-7-2-3-8-24)15-11-18-17(21-12-15)5-6-19(20)22-18;1-14-16(13-22-25(14)10-4-9-24-7-2-3-8-24)15-11-18-17(21-12-15)5-6-19(20)23-18;1-14-15(18-22-16(2,3)17(4,5)23-18)13-21(19-14)12-8-11-20-9-6-7-10-20;1-14-15(18-22-16(2,3)17(4,5)23-18)13-19-21(14)12-8-11-20-9-6-7-10-20;1-7-8(6-12-13-7)11-14-9(2,3)10(4,5)15-11/h2*5-6,11-13H,2-4,7-10H2,1H3;2*13H,6-12H2,1-5H3;6H,1-5H3,(H,12,13).
What are the key properties of 2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole?
2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole has a molecular weight of 1558.33 g/mol, XLogP of 12.85, 21 rotatable bonds, 1 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 2-chloro-7-[3-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;2-chloro-7-[5-methyl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]-1,5-naphthyridine;3-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-1-(3-pyrrolidin-1-ylpropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is sourced from PubChem (CID 161342767), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).